Although the cause(s) of Alzheimer’s disease in the majority of cases remains elusive, it has long been associated with hypertension. In animal models of the disease, hypertension has been shown to exacerbate Alzheimer-like pathology and behavior, while in humans, hypertension during mid-life increases the risk of developing the disease later in life. Unfortunately, once individuals […]
Significant Improvement in Cognition in Mild to Moderately Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation: Case Series Report
Abstract Objective: This study investigated whether patients with mild to moderately severe dementia or possible Alzheimer’s disease (AD) with Mini-Mental State Exam (MMSE) Baseline scores of 10–24 would improve when treated with near-infrared photobiomodulation (PBM) therapy. Background: Animal studies have presented the potential of PBM for AD. Dysregulation of the brain’s default mode network (DMN) has been […]
Photobiomodulation Response From 660 nm is Different and More Durable Than That From 980 nm
A study examining the effects and mechanism of action of photobiomodulation (PBM) using two commonly employed wavelengths—660 nm red light and 980 nm infrared light—found that ~660 nm red light exposure led to a more prolonged stimulation of adenosine triphosphate (ATP) production. Related: Near Infrared Light Improves Fat Graft Viability Researchers at the Wellman Center for Photomedicine measured […]